Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Global Market

6.55USD
23 Jan 2015
Change (% chg)

$-0.06 (-0.91%)
Prev Close
$6.61
Open
$6.52
Day's High
$6.66
Day's Low
$6.40
Volume
11,374
Avg. Vol
6,737
52-wk High
$23.88
52-wk Low
$6.31

GNCA.OQ

Chart for GNCA.OQ

About

Genocea Biosciences, Inc. is a United States-based clinical-stage company that develops T cell vaccines. The Company utilizes T cell immunity to develop the next generation of vaccines. It designs vaccines using ATLAS, its technology platform. It identifies T cell antigens to induce immune responses. Its pipeline of T cell... (more)

Overall

Beta: --
Market Cap(Mil.): $115.35
Shares Outstanding(Mil.): 17.61
Dividend: --
Yield (%): --

Financials

  GNCA.OQ Industry Sector
P/E (TTM): -- 40.21 40.82
EPS (TTM): -2.09 -- --
ROI: -101.01 19.07 18.35
ROE: -- 19.85 19.25
Search Stocks

Competitors

  Price Chg
Novartis AG (NOVN.VX) CHF85.50 +1.20
Pfizer Inc. (PFE.N) $32.45 -0.36
Merck & Co., Inc. (MRK.N) $62.49 -0.10
Sanofi SA (SASY.PA) €83.58 +2.41
AstraZeneca plc (AZN.L) 4,733.50p +44.00
GlaxoSmithKline plc (GSK.L) 1,500.00p +11.50
Vical Incorporated (VICL.OQ) $1.04 +0.01

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks